High Baseline Neutrophil-to-Lymphocyte Ratio Could Serve as a Biomarker for Tumor Necrosis Factor-Alpha Blockers and Their Discontinuation in Patients with Ankylosing Spondylitis.
Dong-Hyuk MoonAran KimByung-Wook SongYun-Kyung KimGeun-Tae KimEun-Young AhnMin-Wook SoSeung-Geun LeePublished in: Pharmaceuticals (Basel, Switzerland) (2023)
NLR may be a potential marker for predicting the clinical response and persistence of TNF-α blockers in AS patients.